[I Brazilian Guidelines for cardiovascular prevention]

Arq Bras Cardiol. 2013 Dec;101(6 Suppl 2):1-63. doi: 10.5935/abc.2013S012.

[Article in Portuguese]

Authors

A F Simão, D B Precoma, J P Andrade, Filho H Correa, J F K Saraiva, G M M Oliveira, A L B Murro, A Campos, A Alessi, A Avezum Jr, A C Achutti, A C M G Miguel, A C S Sousa, A M P Lotemberg, A P Lins, A A Falud, A A Brandão, A F Sanjuliani, A S Sbissa, Filho A C Alencar, A H Herdy, C A Polanczyk, C J Lantieri, C A Machado, C Scherr, C Stoll, C Amodeo, C G S Araújo, D Saraiva, E H Moriguchi, E T Mesquita, F A H Fonseca, G P Campos, G P Soares, G S Feitosa, H T Xavier, I Castro, I C B Giuliano, I V Rivera, I C B Guimaraes, J S Issa, J R M Souza, Neto J R Faria, L B N Cunha, L C Pellanda, L A Bortolotto, M C Bertolami, M H Miname, M A M Gomes, M Tambascia, M V B Malachias, M A M Silva, M C O Izar, M E C Magalhães, M S C Bacellar, M Milani, M Wajngarten, N Ghorayeb, O R Coelho, P B Villela, P C B V Jardim, R D Santos Filho, R Stein, R S L Cassani, R I D'Avila, R M Ferreira, R B Barbosa, R M S Povoa, S E Kaiser, S C Ismael, T Carvalho, V Z R Giraldez, W Coutinho, W K S B Souza; Sociedade Brasileira de Cardiologia

PMID: 24554026
DOI: 10.5935/abc.2013S012

No abstract available

Publication types

Practice Guideline

MeSH terms

Aspirin / therapeutic use
Brazil
Cardiovascular Diseases / prevention & control*
Evidence-Based Medicine
Female
Health Promotion*
Humans
Hypertension / prevention & control
Meta-Analysis as Topic
Quality of Life
Randomized Controlled Trials as Topic
Risk Assessment
Risk Factors
Treatment Outcome

Substances

Aspirin